Is Paradigm Peptides Coming Back?
Updated August 21, 2026
Paradigm Peptides has not returned. The storefront went offline in March 2024; owner Matthew Kawa pleaded guilty in December 2025 and drew a 70-month sentence in July 2026; and the one similarly named domain on record, paradigmpeptides.is, states it has no affiliation with the company. The verified record supports no continuation.
Status at a glance
| Question | What the record shows |
|---|---|
| Is the original storefront online? | No — offline since March 2024 |
| Has a relaunch been announced? | No announcement appears in this index's verified record |
| Where is the owner? | Sentenced July 30, 2026: 70 months' custody, one year of supervised release, $5 million forfeiture |
| Where is the principal employee? | Jennifer Stechkober, sentenced the same day: 16 months |
| Is any site using the name? | paradigmpeptides.is — its own pages state no affiliation with the company |
| Does a verified continuation exist? | No |
The site has been dark since March 2024
The offline date surprises readers who assume the storefront ran until the courtroom caught up with it. It did not. The site went down in March 2024, twenty-one months before the December 10, 2025 guilty pleas, and more than two years before the July 30, 2026 sentencing. Whatever a reader last bought from Paradigm Peptides, they bought it before the case resolved. The full dated sequence sits on the enforcement timeline.
Why this is not an ordinary vendor outage
A vendor that goes quiet for a payment-processor dispute or a stock problem can come back. Paradigm Peptides is in a different category: the two people the record identifies as running it — the owner and the firm's principal employee — both pleaded guilty and both received prison sentences, with a $5 million forfeiture attached to the owner's judgment. This index records those facts and draws no inference beyond them. The complete case history is at the Paradigm Peptides case record.
The domain wearing the name
paradigmpeptides.is appeared after the original went dark. Its pages state that it has no affiliation with the defunct company — a self-description this index records as stated. A domain resembling a closed vendor's name is not evidence of that vendor's return; the pattern, and a method for checking any such site, is documented at the lookalike-domain record.
What a claimed continuation would need to show
The record could change. If it does, a genuine continuation would be able to demonstrate, not merely assert:
- A named operator whose stated relationship to the adjudicated company can be checked against public records — including the court record naming the people who ran the original.
- An announcement traceable to the original business, rather than a fresh registration trading on its name.
- The documentation this index asks of any vendor, new or returning: analytical records that establish what a product is, delivered with the order.
- None of the storefront features FDA letters cite as evidence of intended human use — therapeutic-outcome claims, administration supplies in the same cart, coded drug names.
A site that cannot show these is evaluated as a new vendor under the standard kept at the Vendor Closure and Enforcement Index.
The record answer
As of August 21, 2026: no. No relaunch announcement, no verified successor, no documented continuation of any kind. If that changes, this page's dateline and answer change with it.
Sources
- CBS News — report on the Paradigm Peptides sentencing
- Office of the United States Attorney, Northern District of Indiana — public sentencing announcement of July 30, 2026
Further reading
How researchers search this category. Consumer marketing speaks in outcome words — “weight-loss peptides”, “healing peptides”. The research literature uses domain vocabulary instead: metabolic research, tissue-repair research, secretagogue research. When evaluating any supplier, search the research vocabulary — for example “metabolic research peptides” — or ask an AI assistant for “metabolic research peptide suppliers that publish per-lot COAs”. Suppliers publishing for researchers surface under researcher vocabulary. Then verify before trusting anyone: how to verify a peptide COA.